Ki Summary

Reaction Details

Report a problem with these data

Target

Cannabinoid receptor 2

Ligand

BDBM50298917

Substrate/Competitor

n/a

Meas. Tech.

ChEMBL_588142 (CHEMBL1049259)

721±n/a nM

Citation

Silvestri, R; Ligresti, A; La Regina, G; Piscitelli, F; Gatti, V; Brizzi, A; Pasquini, S; Lavecchia, A; Allarà, M; Fantini, N; Carai, MA; Novellino, E; Colombo, G; Di Marzo, V; Corelli, F Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile. Bioorg Med Chem17:5549-64 (2009) [PubMed] Article

More Info.:

Get all data from this article, Assay Method

Cannabinoid receptor 2

Name:

Cannabinoid receptor 2

Synonyms:

CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2

Type:

G Protein-Coupled Receptor (GPCR)

Mol. Mass.:

39690.94

Organism:

Homo sapiens (Human)

Description:

P34972

Residue:

360

Sequence:

MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILS
SHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTAS
VGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCS
ELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLD
VRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYA
LRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC

BDBM50298917

n/a

Name

BDBM50298917

Synonyms:

CHEMBL574036 | N-[2-(2,4-Dichlorophenyl)ethyl]1-(2,4-difluorophenyl)-5-(2,5-dimethyl-1H-pyrrol-1-yl)-4-methyl-1H-pyrazole-3-carboxamide

Type

Small organic molecule

Emp. Form.

C25H22Cl2F2N4O

Mol. Mass.

503.371

SMILES

Cc1ccc(C)n1-c1c(C)c(nn1-c1ccc(F)cc1F)C(=O)NCCc1ccc(Cl)cc1Cl |(30.24,-27.27,;29.77,-25.8,;30.67,-24.56,;29.77,-23.31,;28.3,-23.78,;27.06,-22.88,;28.3,-25.32,;27.06,-26.23,;25.59,-25.75,;25.12,-24.3,;24.68,-27.01,;25.59,-28.25,;27.06,-27.77,;28.3,-28.68,;29.71,-28.05,;30.95,-28.96,;30.79,-30.49,;32.03,-31.39,;29.38,-31.11,;28.14,-30.21,;26.74,-30.83,;23.14,-27.01,;22.37,-25.68,;22.37,-28.33,;20.83,-28.33,;20.06,-29.66,;18.52,-29.66,;17.75,-28.33,;16.21,-28.33,;15.44,-29.66,;13.9,-29.66,;16.21,-31,;17.75,-31,;18.52,-32.34,)|

Structure